Jpmorgan Chase & CO 2seventy Bio, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 482,204 shares of TSVT stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
482,204
Previous 514,767 6.33%
Holding current value
$1.27 Million
Previous $2.43 Million 41.66%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$2.89 - $5.21 $94,107 - $169,653
-32,563 Reduced 6.33%
482,204 $1.42 Million
Q3 2024

Dec 26, 2024
SELL
$3.85 - $5.05 $68,010 - $89,208
-17,665 Reduced 3.32%
514,767 $2.43 Million
Q3 2024

Nov 08, 2024
SELL
$3.85 - $5.05 $68,010 - $89,208
-17,665 Reduced 3.32%
514,767 $2.43 Million
Q2 2024

Dec 26, 2024
BUY
$3.6 - $5.79 $63,594 - $102,280
17,665 Added 3.43%
532,432 $2.05 Million
Q2 2024

Aug 12, 2024
SELL
$3.6 - $5.79 $1.55 Million - $2.5 Million
-431,280 Reduced 44.75%
532,432 $2.05 Million
Q1 2024

Dec 26, 2024
BUY
$3.09 - $6.0 $1.39 Million - $2.69 Million
448,945 Added 87.21%
963,712 $5.16 Million
Q1 2024

May 10, 2024
SELL
$3.09 - $6.0 $155,439 - $301,824
-50,304 Reduced 4.96%
963,712 $5.16 Million
Q4 2023

Dec 26, 2024
BUY
$1.57 - $4.58 $783,820 - $2.29 Million
499,249 Added 96.99%
1,014,016 $4.33 Million
Q4 2023

Feb 12, 2024
SELL
$1.57 - $4.58 $530,426 - $1.55 Million
-337,851 Reduced 24.99%
1,014,016 $4.33 Million
Q3 2023

Nov 14, 2023
BUY
$3.14 - $11.2 $564,110 - $2.01 Million
179,653 Added 15.33%
1,351,867 $5.3 Million
Q2 2023

Aug 11, 2023
SELL
$8.45 - $12.48 $3.48 Million - $5.14 Million
-411,467 Reduced 25.98%
1,172,214 $11.9 Million
Q1 2023

May 18, 2023
BUY
$9.21 - $14.98 $263,783 - $429,042
28,641 Added 1.84%
1,583,681 $16.2 Million
Q1 2023

May 11, 2023
BUY
$9.21 - $14.98 $5.27 Million - $8.58 Million
572,506 Added 58.27%
1,555,040 $15.9 Million
Q4 2022

Feb 13, 2023
BUY
$8.57 - $17.0 $499,562 - $990,964
58,292 Added 6.31%
982,534 $9.21 Million
Q3 2022

Nov 14, 2022
BUY
$12.56 - $17.54 $415,221 - $579,854
33,059 Added 3.71%
924,242 $13.4 Million
Q2 2022

Aug 11, 2022
BUY
$10.55 - $18.81 $4.31 Million - $7.68 Million
408,376 Added 84.58%
891,183 $11.8 Million
Q1 2022

May 11, 2022
SELL
$11.67 - $26.72 $256,704 - $587,759
-21,997 Reduced 4.36%
482,807 $8.24 Million
Q4 2021

Feb 10, 2022
BUY
$13.77 - $42.56 $6.95 Million - $21.5 Million
504,804 New
504,804 $12.9 Million

Others Institutions Holding TSVT

# of Institutions
127
Shares Held
44.8M
Call Options Held
17.3K
Put Options Held
2.9K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $100M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email